MedTrace Logo

Prehabilitation Plus ERAS Versus ERAS in Gynecologic Oncology: a Randomized Clinical Trial

NCT04596800 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 194

Last updated 2023-10-31

No results posted yet for this study

Summary

Prospective, interventionist, controlled and randomized study to test the effectiveness of a multimodal prehabilitation protocol in patients who will undergo gynecological surgery.

Conditions

  • Gynecologic Cancer
  • Enhanced Recovery After Surgery

Interventions

OTHER

Prehabilitation Program + Enhanced Recovery After Surgery

Prehabilitation Program (nutrition + exercise + psychological counseling) + ERAS protocol

OTHER

Enhanced Recovery After Surgery

ERAS

Sponsors & Collaborators

  • Instituto Brasileiro de Controle do Cancer

    lead OTHER

Principal Investigators

  • Andre Lopes, MD · Instituto Brasileiro de Controle do Cancer

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-05
Primary Completion
2024-10-31
Completion
2024-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04596800 on ClinicalTrials.gov